Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register

Arthritis Research and Therapy

Volumn 8, Issue 4, 2006, Pages

  Symmons, Deborah P M ^a   Silman, Alan J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HLA DR ANTIGEN; METHOTREXATE; STEROID; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT;

ANGINA PECTORIS; ANTIBODY DETECTION; BONE EROSION; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COMORBIDITY; CORONARY RISK; DISABILITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HOMOZYGOSITY; HORMONE SYNTHESIS; HUMAN; ISCHEMIC HEART DISEASE; JOINT RADIOGRAPHY; MORTALITY; NONHODGKIN LYMPHOMA; PATIENT COMPLIANCE; POLYARTHRITIS; PREDICTION; PROGNOSIS; REGISTER; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYMPTOM; TREATMENT OUTCOME; UNITED KINGDOM; X RAY; ARTHRITIS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; CLASSIFICATION; DISABLED PERSON; LYMPHOMA, NON-HODGKIN; PATHOPHYSIOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; CARDIOVASCULAR DISEASES; COMORBIDITY; DISABLED PERSONS; HUMANS; LYMPHOMA, NON-HODGKIN; REGISTRIES; REMISSION INDUCTION; RISK FACTORS;

EID: 33748563609     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1979     Document Type: Review

References (38)

1. Bunn DK, Shepstone L, Galpin LM, Wiles NJ, Symmons DP: The NOAR Damaged Joint Count (NOAR-DJC): a clinical measure for assessing articular damage in patients with early inflammatory polyarthritis including rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:1519-1525.
2. Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
3. Kirwan JR, Reeback JS: Stanford Health Assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986, 25:206-209.
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
5. Wiles N, Symmons DPM, Harrison B, Barrett E, Barrett JH, Scott DGI, Silman AJ: Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 1999, 42:1339-1346.
6. Huizinga TW, Amos Cl, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, et al: Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005, 52:3433-3438.
7. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, et al: A new model for an etiology of rheumatoid arthritis. Arthritis Rheum 2006, 54:38-46.
8. Harrison B, Symmons D: Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 2000, 39:939-949.
9. Pinals RS, Masi AT, Larsen RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981, 24: 1308-1315.
10. van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB: Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis. J Rheumatol 1991, 18:1285-1289.
11. Prevoo ML, 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
12. van Gestel AM, Haagsma CJ, van Riel PL: Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998, 41:1845-1850.
13. Green M, Marzo-Ortega H, Wakefield RJ, Astin P, Proudman S, Conaghan PG, Hordon L, Emery P: Predictors of outcome in patients with oligoarthritis: results of a protocol of intraarticular corticosteroids to all clinically active joints. Arthritis Rheum 2001, 44:1177-1783.
14. Pincus T, Callahan LF: Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 1985, 38:973-984.
15. Wiles NJ, Dunn G, Barrett EM, Harrison BJ, Silman AJ, Symmons DP: One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater after presentation with inflammatory polyarthritis with greater accuracy than at baseline. J Rheumatol 2000, 27:2360-2366.
16. Wiles N, Dunn G, Barrett E, Silman A, Symmons D: Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. J Clin Epidemiol 2000, 53:988-996.
17. Bukhari M, Lunt M, Scott DGI, Symmons D, Silman A: Increasing age at symptom onset is strongly associated with worse radiologic damage both at presentation and follow-up in an inception cohort of patients with inflammatory polyarthritis [abstract]. Arthritis Rheum 2005, 52(Suppl):S451.
18. Bukhari M, Harrison B, Lunt M, Scott DG, Symmons DP, Silman AJ: Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum 2001, 44:1248-1253.
19. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ: Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002, 46:906-912.
20. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B: Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004, 63:1090-1095.
21. Bukhari M, Thomson W, Scott DGI, Symmons DPM, Silman AJ: Antibodies to cyclic citrillinated peptide and rheumatoid factor in early undifferentiated inflammatory arthritis: results from the Norfolk Arthritis Register. Rheumatology 2006, 45 (Suppl 1):i93.
22. Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP: Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002,46:2010-2019.
23. Goodson N, Marks J, Lunt M, Symmons D: Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann Rheum Dis 2005, 64:1595-1601.
24. Marshall AT, Bunn DK, Symmons DPM, Harvey I, Shepstone L, Oakes S: Prevalence of self-reported angina in a community-based inception cohort of patients with inflammatory arthritis [abstract]. Arthritis Rheum 2005, 52(Suppl):S329.
25. Franklin J, Lunt M, Bunn D, Symmons DPM, Silman A: Increased risk of lymphoma observed in a 10 year prospective study of a large primary-care based inception cohort of patients with inflammatory polyarthritis [abstract]. Arthritis Rheum 2005, 52 (Suppl):S264.
26. Wiles NJ, Lunt M, Barrett EM, Bukhari M, Silman AJ, Symmons DP, Dunn G: Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum 2001, 44:1033-1042.
27. Bukhari MA, Wiles NJ, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ: Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 2003,48:46-53.
28. Hider SL, Lunt M, Bunn D, Manning S, Symmons DPM, Silman AJ: Can we predict the outcome of methotrexate treatment in inflammatory polyarthritis using clinical variables? Rheumatology 2006,45(Suppl 1):154.
29. Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, Barrett E, Silman A: The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum 1999,42:2174-2183.
30. Goodson NJ, Tellam DJ, Barton A, Lunt M, Barrett EM, Silman AJ, Symmons DPM: HLA DRB1 shared epitope bearing alleles associated with RA disease severity also predict mortality in patients with inflammatory polyarthritis. Rheumatology (Oxford) 2003, 42 (Suppl 1):7.
31. Barton A, Platt H, Salway F, Symmons D, Barrett E, Bukhari M, Lunt M, Zeggini E, Eyre S, Hinks A, et al.: Polymorphisms in the tumour necrosis factor gene are not associated with severity of inflammatory polyarthritis. Ann Rheum Dis 2004, 63:280-284.
32. Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, Silman A: Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J Rheumatol 2004, 31:442-447.
33. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, et al: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402.
34. Barton A, Bowes J, Eyre S, Symmons D, Worthington J, Silman A: Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis. Ann Rheum Dis 2005, 64:1311-1315.
35. Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, Yamanaka H, Tomatsu T, Kamatani N: Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum 2005,52:3054-3057.
36. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC: A functional haplotype of the PADI4 genen associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 2006, 54:90-96.
37. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, Wolfe F, Kastner DL, Alfredsson L, Altshuler D, Gregersen PK, Klareskog L, Rioux JD: Replication of putative candidate-gene associations with rheumatoid arthritis in >4000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4 and PADI4. Am J Hum Genet 2005, 77:1044-1060.
38. Caponi L, Petit-Teixeira E, Sebbag M, Bongiorni F, Moscato S, Pratesi F, Pierlot C, Osorio J, Chapuy-Regaud S, Guerrin M, Cornelis F, Serre G, Migliorini P; ECRAF: A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis 2005, 64:587-593.